05/25/2026
6 studies. One clear direction.
MSC IV therapy is reshaping how we think about aging, not as something to manage, but as something we can actually influence at a biological level.
Inflammation, immune decline, mitochondrial dysfunction, and cognitive resilience. Researchers are finding that regenerative signaling therapy may be able to address several of these simultaneously.
Our latest post on the blog breaks down all six studies, and how this fits into what we’re doing at The Longevity Protocol with the de Leon IV. 🔗 in bio.